Dr. Chovatiya discusses safety data on upadacitinib and abrocitinib for the treatment of atopic dermatitis.
In a recap of his Maui Derm NP+PA Fall 2023 session, Dr. Zirwas discusses some of the most exciting new papers published this year in atopic dermatitis research.
Victoria Lazareth discussed topics covered during the Surgical Procedural Workshop, which took place during the meeting’s Pre-Conference Day.
Doug DiRuggiero discusses oral JAK inhibitors for patients with atopic dermatitis and how these new agents will benefit patients with AD.
In a recap of his Maui Derm NP+PA Fall 2023 session, Dr. Rosen overviews updates on COVID-19 and long COVID, monkeypox, HIV, and fungal infections.